Echogenesis Therapeutics Inc.

Pittsburgh, PA

UEI
NZCGRHMV5ZQ4
CAGE
Not on record
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
5403 Friendship Ave, Pittsburgh, PA 15232, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Echogenesis Therapeutics Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Cell type-specific gene therapy approach for tomt-linked congenital hearing loss - project summary/abstract hearing loss… Grant · R41DC022471 National Institute on Deafness and Other Communincation Disorders $611,256

Quick answers

What is Echogenesis Therapeutics Inc.'s UEI?

Echogenesis Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is NZCGRHMV5ZQ4.

Where is Echogenesis Therapeutics Inc. located?

Echogenesis Therapeutics Inc.'s physical address in SAM.gov is 5403 Friendship Ave, Pittsburgh, PA 15232, USA.

Is Echogenesis Therapeutics Inc. registered in SAM.gov?

Yes. Echogenesis Therapeutics Inc.'s SAM.gov registration is active through December 22, 2026.

What is Echogenesis Therapeutics Inc.'s most recent federal award?

Echogenesis Therapeutics Inc.'s most recent federal grant award is Cell type-specific gene therapy approach for tomt-linked congenital hearing loss - project summary/abstract hearing loss… (R41DC022471), from National Institute on Deafness and Other Communincation Disorders, on January 6, 2025.

On GovTribe

See Echogenesis Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors